Log In
Sign Up
Trastuzumab
Indications
Metastatic breast cancer in patients whose tumors overexpress the HER2 protein and they have received at least one chemotherapy regimen previously. It is also combined with paclitaxel for treatment of patients with metastatic breast cancer whose tumors overexpress the HER2 protein and who have not received chemotherapy for their metastatic disease.
Dose/Application
4mg/kg I.V over 90 mins then 2 mg/kg every 7 days
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Trasturel Inj 150mg/vial 1 KES55,000.00
Trasturel Inj 440mg/vial 1 KES120,000.00
Hertraz. inj 150mg 1 KES35,000.00
Hertraz. inj 440mg 1 KES87500.00
Herceptin. inj 150mg 1 KES61,100.00
Herceptin. inj 440mg 1 KES171,070.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us